BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 3566787)

  • 21. Buthionine sulfoximine inhibition of glutathione biosynthesis enhances hepatic lipid peroxidation in rats during acute ethanol intoxication.
    Kera Y; Ohbora Y; Komura S
    Alcohol Alcohol; 1989; 24(6):519-24. PubMed ID: 2576368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytotoxicity of alkylating agents in isolated rat kidney proximal tubular and distal tubular cells.
    Lash LH; Woods EB
    Arch Biochem Biophys; 1991 Apr; 286(1):46-56. PubMed ID: 1897958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The deleterious effect of buthionine sulfoximine, a glutathione-depleting agent, on the cisplatin toxicity in mice.
    Ishikawa M; Takayanagi Y; Sasaki K
    Jpn J Pharmacol; 1990 Apr; 52(4):652-5. PubMed ID: 2342233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subcellular glutathione contents in isolated hepatocytes treated with L-buthionine sulfoximine.
    Romero FJ; Sies H
    Biochem Biophys Res Commun; 1984 Sep; 123(3):1116-21. PubMed ID: 6487323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxic effects of acute glutathione depletion by buthionine sulfoximine and dimethylfumarate on murine mammary carcinoma cells.
    Dethlefsen LA; Lehman CM; Biaglow JE; Peck VM
    Radiat Res; 1988 May; 114(2):215-24. PubMed ID: 3375425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic modulation of reduced glutathione circadian rhythms with buthionine sulfoximine: relationship with cisplatin toxicity in mice.
    Li XM; Metzger G; Filipski E; Boughattas N; Lemaigre G; Hecquet B; Filipski J; Levi F
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):281-90. PubMed ID: 9144445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of genotoxicity of azathioprine by intracellular glutathione in hepatocytes.
    Nagafuchi K; Miyazaki K
    J Cancer Res Clin Oncol; 1991; 117(4):321-5. PubMed ID: 2066352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo modulation of glutathione by buthionine sulfoximine: effect on marrow response to melphalan.
    Russo A; Tochner Z; Phillips T; Carmichael J; DeGraff W; Friedman N; Fisher J; Mitchell JB
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1187-9. PubMed ID: 3744938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of effect of glutathione depletion by L-buthionine-S,R-sulfoximine on gentamicin nephrotoxicity in rats.
    Wu DF; Griffith OW; Reidenberg MM
    Pharmacology; 1990; 40(5):250-7. PubMed ID: 2274571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of glutathione depletion by buthionine sulfoximine on radiosensitization by oxygen and misonidazole in vitro.
    Shrieve DC; Denekamp J; Minchinton AI
    Radiat Res; 1985 Jun; 102(3):283-94. PubMed ID: 4070545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glutathione depletion by buthionine sulfoximine induces oxidative damage to DNA in organs of rabbits in vivo.
    Gokce G; Ozsarlak-Sozer G; Oktay G; Kirkali G; Jaruga P; Dizdaroglu M; Kerry Z
    Biochemistry; 2009 Jun; 48(22):4980-7. PubMed ID: 19374446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depletion of tumour versus normal tissue glutathione by buthionine sulfoximine.
    Lee FY; Allalunis-Turner MJ; Siemann DW
    Br J Cancer; 1987 Jul; 56(1):33-8. PubMed ID: 3620316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
    Ali-Osman F; Antoun G; Wang H; Rajagopal S; Gagucas E
    Mol Pharmacol; 1996 Jun; 49(6):1012-20. PubMed ID: 8649339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo selective modulation of tissue glutathione in a rat mammary carcinoma model.
    Baruchel S; Wang T; Farah R; Jamali M; Batist G
    Biochem Pharmacol; 1995 Oct; 50(9):1505-8. PubMed ID: 7503802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of buthionine sulphoximine (BSO) on glutathione depletion and xenobiotic biotransformation.
    Drew R; Miners JO
    Biochem Pharmacol; 1984 Oct; 33(19):2989-94. PubMed ID: 6148944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular glutathione depletion by diethyl maleate or buthionine sulfoximine: no effect of glutathione depletion on the oxygen enhancement ratio.
    Mitchell JB; Russo A; Biaglow JE; McPherson S
    Radiat Res; 1983 Nov; 96(2):422-8. PubMed ID: 6647769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of buthionine sulfoximine, an inhibitor of glutathione biosynthesis, on the selenium-induced lethality in mice.
    Ishikawa M; Takayanagi G; Sasaki K
    Jpn J Pharmacol; 1988 Oct; 48(2):283-6. PubMed ID: 3210451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracerebroventricular administration of L-buthionine sulfoximine: a method for depleting brain glutathione.
    Pileblad E; Magnusson T
    J Neurochem; 1989 Dec; 53(6):1878-82. PubMed ID: 2809598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of chronic inhibition of glutathione biosynthesis on cholesterol and bile acid metabolism in rats.
    Hassan AS
    Biochim Biophys Acta; 1988 Nov; 963(2):131-8. PubMed ID: 3196722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Buthionine sulfoximine-induced cytostasis does not correlate with glutathione depletion.
    Kang YJ; Enger MD
    Am J Physiol; 1992 Jan; 262(1 Pt 1):C122-7. PubMed ID: 1733228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.